Related Experiment Video
Updated: Aug 24, 2025
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Published on: January 16, 2013
In vivo targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic
Ruimin Hu1, Yang Yang1, Guojing Song1
1Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Abstract:
Chronic bacterial prostatitis usually occurs in men and seriously affects the quality of life of patients. The efficacy of chronic bacterial prostatitis treatment is limited by the difficulty for free drugs (e.g., antibiotics) to penetrate the prostate epithelium and target inflammatory tissues. The advent of nanotechnology offers the possibility to address this issue, such as the development of targeted nanoparticle delivery strategies that may overcome these important limitations. The physicochemical properties of nanoparticles, such as particle size, shape and surface modification ligands, determine their targeting effectiveness. In this study, nanoparticles with different physicochemical properties were prepared to explore and confirm their targeting capacities to inflammatory prostate tissues of chronic bacterial prostatitis, focusing on the effects of size and different modification ligands on the targeting performance. In vivo and ex vivo imaging results verified that folic acid-modified nanoparticles with a particle size of 180-190 nm via tail intravenous injection had the optimal targeting efficiency to prostate tissues. Our results provide an experimental basis and reference value for targeted therapy of prostate-related diseases with nanotechnology in the future.
Insights
Targeted nanoparticles show promise for treating chronic bacterial prostatitis. Folic acid-modified nanoparticles, 180-190 nm in size, demonstrated optimal targeting efficiency in prostate tissues.
Area of Science:
- Nanotechnology
- Prostate Disease Research
- Drug Delivery Systems
Background:
- Chronic bacterial prostatitis significantly impacts male quality of life.
- Current treatments are limited by poor drug penetration into prostate tissues.
- Nanotechnology offers potential solutions for targeted drug delivery.
Purpose of the Study:
- To investigate nanoparticle targeting efficiency in chronic bacterial prostatitis models.
- To evaluate the impact of nanoparticle physicochemical properties (size, surface modification) on targeting.
- To identify optimal nanoparticle characteristics for prostate tissue targeting.
Main Methods:
- Preparation of nanoparticles with varying sizes and surface ligands.
- Evaluation of targeting capacity using in vivo and ex vivo imaging techniques.
- Comparison of targeting performance based on particle size and modification ligands.
Main Results:
- Nanoparticle targeting efficiency is influenced by particle size and surface modification.
- Folic acid-modified nanoparticles (180-190 nm) exhibited superior targeting to prostate tissues.
- Optimal targeting was achieved via tail intravenous injection.
Conclusions:
- Nanoparticle characteristics are crucial for effective targeting of inflammatory prostate tissues.
- Folic acid-modified nanoparticles represent a promising strategy for chronic bacterial prostatitis treatment.
- This study provides a foundation for nanotechnology-based therapies in prostate diseases.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013